A controversy has erupted in Keralam over the distribution of risdiplam, a medicine used to treat spinal muscular atrophy (SMA), after parents reportedly discovered labels carrying the words “clinical trial only.” The discovery has raised questions about the medicine's status, safety and suitability for patients, particularly families relying on access to treatment for this serious genetic condition.The issue has triggered a political confrontation, with opposition leaders raising concerns and seeking clarity over the distribution process. -newsn18oc_india News18 Mobile App - https://onelink.to/desc-youtube
Read full article